What about HES in burn patients?: Evaluation of the actual evidence

Following the 2013 alert by the European Medicines Agency (EMA) discouraging the use of hydroxyethyl-starch solutions (HES) in critically ill and burn patients, most specialized units treating burn victims have stopped using HES in this population. But, how well-founded was the EMA alert in this spe...

Full description

Bibliographic Details
Authors: Guilabert, Patricia, Abarca, Luis, Martin, Nuria, Usua, Gemma, Barret Nerín, Juan Pedro, Colomina Soler, M. J. (María José)
Format: article
Status:Versión aceptada para publicación
Publication Date:2018
Country:España
Institution:Universidad de Barcelona
Repository:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/122487
Online Access:https://hdl.handle.net/2445/122487
Access Level:Open access
Keyword:Cremades
Medicaments
Malalts en estat crític
Burns and scalds
Drugs
Critically ill
id ES_deadb87a77fd3db2e2b962cbc4125b04
oai_identifier_str oai:diposit.ub.edu:2445/122487
network_acronym_str ES
network_name_str España
repository_id_str
spelling What about HES in burn patients?: Evaluation of the actual evidenceGuilabert, PatriciaAbarca, LuisMartin, NuriaUsua, GemmaBarret Nerín, Juan PedroColomina Soler, M. J. (María José)CremadesMedicamentsMalalts en estat críticBurns and scaldsDrugsCritically illFollowing the 2013 alert by the European Medicines Agency (EMA) discouraging the use of hydroxyethyl-starch solutions (HES) in critically ill and burn patients, most specialized units treating burn victims have stopped using HES in this population. But, how well-founded was the EMA alert in this specific type of patient? ...Elsevier B.V.2018info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfhttps://hdl.handle.net/2445/122487Articles publicats en revistes (Ciències Clíniques)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésVersió postprint del document publicat a: https://doi.org/10.1016/j.burns.2017.09.023Burns, 2018, vol. 44, num. 3, p. 489-493https://doi.org/10.1016/j.burns.2017.09.023cc-by-nc-nd (c) Elsevier B.V., 2018http://creativecommons.org/licenses/by-nc-nd/3.0/esinfo:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1224872026-05-27T06:46:51Z
dc.title.none.fl_str_mv What about HES in burn patients?: Evaluation of the actual evidence
title What about HES in burn patients?: Evaluation of the actual evidence
spellingShingle What about HES in burn patients?: Evaluation of the actual evidence
Guilabert, Patricia
Cremades
Medicaments
Malalts en estat crític
Burns and scalds
Drugs
Critically ill
title_short What about HES in burn patients?: Evaluation of the actual evidence
title_full What about HES in burn patients?: Evaluation of the actual evidence
title_fullStr What about HES in burn patients?: Evaluation of the actual evidence
title_full_unstemmed What about HES in burn patients?: Evaluation of the actual evidence
title_sort What about HES in burn patients?: Evaluation of the actual evidence
dc.creator.none.fl_str_mv Guilabert, Patricia
Abarca, Luis
Martin, Nuria
Usua, Gemma
Barret Nerín, Juan Pedro
Colomina Soler, M. J. (María José)
author Guilabert, Patricia
author_facet Guilabert, Patricia
Abarca, Luis
Martin, Nuria
Usua, Gemma
Barret Nerín, Juan Pedro
Colomina Soler, M. J. (María José)
author_role author
author2 Abarca, Luis
Martin, Nuria
Usua, Gemma
Barret Nerín, Juan Pedro
Colomina Soler, M. J. (María José)
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Cremades
Medicaments
Malalts en estat crític
Burns and scalds
Drugs
Critically ill
topic Cremades
Medicaments
Malalts en estat crític
Burns and scalds
Drugs
Critically ill
description Following the 2013 alert by the European Medicines Agency (EMA) discouraging the use of hydroxyethyl-starch solutions (HES) in critically ill and burn patients, most specialized units treating burn victims have stopped using HES in this population. But, how well-founded was the EMA alert in this specific type of patient? ...
publishDate 2018
dc.date.none.fl_str_mv 2018
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/122487
url https://hdl.handle.net/2445/122487
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Versió postprint del document publicat a: https://doi.org/10.1016/j.burns.2017.09.023
Burns, 2018, vol. 44, num. 3, p. 489-493
https://doi.org/10.1016/j.burns.2017.09.023
dc.rights.none.fl_str_mv cc-by-nc-nd (c) Elsevier B.V., 2018
http://creativecommons.org/licenses/by-nc-nd/3.0/es
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by-nc-nd (c) Elsevier B.V., 2018
http://creativecommons.org/licenses/by-nc-nd/3.0/es
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv Articles publicats en revistes (Ciències Clíniques)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869421996059656192
score 15,300719

Similar Items